Oncology

The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.

Latest News

3D rendering of lung cancer screening x-ray | Image Credit: © Vector Market- stock.adobe.com
FDA Approves Datopotamab for Treatment of EGFR-Mutated Non-Small Cell Lung Cancer

June 23rd 2025

Datopotamab deruxtecan gains FDA approval, offering new hope for adults with advanced EGFR-mutated non-small cell lung cancer after prior therapies.

Patient with oral chemotherapy -- Image credit: Beaunitta Van Wyk/peopleimages.com | stock.adobe.com
Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

June 23rd 2025

OPC 2025: Adapting Oncology Pharmacy to the Age of AI and Drug Shortages
OPC 2025: Adapting Oncology Pharmacy to the Age of AI and Drug Shortages

June 20th 2025

OPC 2025: Key Studies Shaping Lung Cancer Therapy From ASCO 2025
OPC 2025: Key Studies Shaping Lung Cancer Therapy From ASCO 2025

June 20th 2025

Pharmacist and patient with cancer -- Image credit: NDABCREATIVITY | stock.adobe.com
Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

June 20th 2025

More News